News

The results show that SPP100, the first-in-class direct renin inhibitor, further lowers proteinuria in diabetic patients, independent of blood pressure, when administered on top of losartan, a standard

Prostate specific antigen (PSA) declines were seen in a dose-dependent manner in these patients. In the lowest dose group, after two months of treatment PSA levels declined 45%

Derma Sciences acquired the technology license for an $840,000 up front payment, with certain milestone payments to University of Southern California (USC) based on regulatory and sales milestones,

The company took this global action following direction from the German BfArM and requests from the FDA and other regulators that Bayer temporarily suspend Trasylol marketing in their

The purchase price of the shares was $17 per share. Genoptix sold a total of 4,735,714 shares in the offering, resulting in net proceeds of approximately $72.7 million

The company’s case volume in the first quarter increased to 31,765 cases, up 32%, compared with the same period in 2008. The customer base of oncology and pathology

The exploratory study was designed to determine whether the company should focus on commercializing a blood-stage or a liver-stage malaria prevention drug. Participants in the randomized placebo controlled

As the Phase II trial’s study period covered 48 weeks from curative surgery, the data analysis was performed to evaluate the treatment’s impact when patients with a low

The data published in Cell show that antibodies against PlGF (placental growth factor) can inhibit cancer tumour growth and the development of metastases in preclinical models, without affecting